Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis

Christoph Krisp, Robert Parker, Dana Pascovici, Nicholas K. Hayward, James S. Wilmott, John F. Thompson, Graham J. Mann, Georgina V. Long, Richard A. Scolyer, Mark P. Molloy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis'. Together they form a unique fingerprint.

Medicine & Life Sciences